Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma

Reactivation of Hepatitis B Virus in Patients with Multiple Myeloma

Reactivation of hepatitis B virus (HBV) is a well-known complication in patients with hematological malignancies during or after cytotoxic chemotherapy. If the initiation of antiviral therapy is delayed in patients with HBV reactivation, these patients can develop severe hepatitis and may die of ful...

Full description

Bibliographic Details
Main Authors:	Yutaka Tsukune, Makoto Sasaki, Norio Komatsu
Format:	Article
Language:	English
Published:	MDPI AG 2019-11-01
Series:	Cancers
Subjects:	hepatitis b virus reactivation multiple myeloma novel agents autologous stem cell transplantation
Online Access:	https://www.mdpi.com/2072-6694/11/11/1819

Similar Items

Multiple Myeloma Outpatient Transplant Program in the Era of Novel Agents: State-of-the-Art
by: Massimo Martino, et al.
Published: (2020-11-01)

Multiple myeloma: Looking beyond standards
by: Esha Kaul, et al.
Published: (2016-01-01)

Major advances in the treatment of multiple myeloma in American Society of Hematology annual meeting 2020
by: Jianhua Du, et al.
Published: (2021-12-01)

New Treatment Methods in Multiple Myeloma
by: Jakab Szende, et al.
Published: (2017-06-01)

Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study
by: Anna Waszczuk-Gajda, et al.
Published: (2022-06-01)

Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001–2010: a retrospective, population based analysis
by: Jon-Magnus Tangen, et al.
Published: (2018-08-01)

Clinical Outcomes of Autologous Hematopoietic Stem Cell Transplant in Multiple Myeloma Patients: A 5-year Experience from a Single Centre in North India
by: Nitin Sood, et al.
Published: (2023-04-01)

Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
by: Lakshmi Yarlagadda, et al.
Published: (2021-08-01)

A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation
by: Wancheng Guo, et al.
Published: (2024-03-01)

Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
by: Malkan Umit Yavuz, et al.
Published: (2021-01-01)

Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
by: Kristin Larsen, et al.
Published: (2022-03-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy
by: Ye. I. Darskaya, et al.
Published: (2014-07-01)

Bortezomib plus dexamethasone induction followed by autologous stem cell transplantation in multiple myeloma: A study from India
by: Jeevan Kumar
Published: (2016-07-01)

Role of Stem Cell Transplantation in Multiple Myeloma
by: Srinivas Devarakonda, et al.
Published: (2021-02-01)

Prognostic Value of Lenalidomide Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM); A Single Center Experience-A Retrospective Study
by: Ali Eser, et al.
Published: (2021-04-01)

Survival and response deepening after autologous transplantation in patients with multiple myeloma in Chile
by: María Carolina Guerra, et al.
Published: (2022-12-01)

How I manage frontline transplant-eligible multiple myeloma in Italy
by: Vittorio Montefusco, et al.
Published: (2020-09-01)

Double Autologous Stem Cell Transplantation in a Case of Non-secretory Multiple Myeloma
by: Lázár Erzsébet, et al.
Published: (2016-12-01)

Circulating monocyte subsets in multiple myeloma patients receiving autologous stem cell transplantation – a study of the preconditioning status and the course until posttransplant reconstitution for a consecutive group of patients
by: Ida Marie Rundgren, et al.
Published: (2019-11-01)

Enterococcus raffinosus infection with atypical hemolytic uremic syndrome in a multiple myeloma patient after autologous stem cell transplant
by: Pankaj Mathur, et al.
Published: (2017-09-01)

Multiple Myeloma: An Overview of the Current and Novel Therapeutic Approaches in 2020
by: Arthur Bobin, et al.
Published: (2020-10-01)

VAD Chemotherapy Versus Bortezomib Containing Regimens As Remission Induction For ASCT in Multiple Myeloma: A Single Center Experience
by: Aysun Senturk Yikilmaz, et al.
Published: (2020-10-01)

The Evolution of Intracardiac Hemodynamics Post Autologous Stem Cell Transplant in a Case of Multiple Myeloma Associated with Severe Tricuspid and Mitral Valve Insufficiency
by: Tudor Cezara-Iuliana, et al.
Published: (2017-12-01)

AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA: IS IT STILL THE RIGHT CHOICE?
by: Patrizia Tosi
Published: (2014-07-01)

UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA
by: Patrizia Tosi, et al.
Published: (2012-11-01)

Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma
by: Bergantim Rui, et al.
Published: (2012-11-01)

Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis
by: Weerapat Owattanapanich, et al.
Published: (2018-11-01)

Recent Advances in the Treatment of Patients with Multiple Myeloma
by: Mario A. Legarda, et al.
Published: (2020-11-01)

Risk Factors for Catheter-Related Thrombosis in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
by: Anna Hoppe, et al.
Published: (2021-09-01)

Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go?
by: Sonia Morè, et al.
Published: (2022-02-01)

Relapsed/Refractory Multiple Myeloma: A Review of Available Therapies and Clinical Scenarios Encountered in Myeloma Relapse
by: Parva Bhatt, et al.
Published: (2023-02-01)

Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era
by: Huixing Zhou, et al.
Published: (2023-04-01)

Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation
by: Chuanying Geng, et al.
Published: (2022-12-01)

Stem Cell Mobilization with Ixazomib and G-CSF in Patients with Multiple Myeloma
by: Selina Bühler, et al.
Published: (2023-01-01)

Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
by: Simone A. Minnie, et al.
Published: (2021-03-01)

Immune microenvironment characteristics in multiple myeloma progression from transcriptome profiling
by: Jin Wang, et al.
Published: (2022-08-01)

Validation of prognostic factors and survival of patients with multiple myeloma in a real-life autologous stem cell transplantation setting: a Swiss single centre experience
by: P Samaras, et al.
Published: (2011-05-01)

Changes in Laboratory Indexes for Multiple Myeloma Patients Before and After Autologous Stem Cell Transplant
by: Zhao R, et al.
Published: (2023-12-01)

Socioeconomic Factors and Survival of Multiple Myeloma Patients
by: Kamal Chamoun, et al.
Published: (2021-02-01)